Trade Summary

6 days ago, Shah Gaurav, serving as CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 55,684 shares at $3.09 per share, for a total transaction value of $171,840.82. Following this transaction, Shah Gaurav now holds 1,061,724 shares of RCKT.

This sale represents a 4.98% decrease in Shah Gaurav's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, May 21, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 7:47 PM ET, 5 days after the trade was made.

ROCKET PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.